Alteration of cyclin D1 in gastric carcinoma and its clinicopathologic significance

Table 1 Cyclin D1 expression in early stage gastric carcinoma (EC), advanced gastric carcinoma (AC) and lymph node me-tastasis (LNM) and five-year survival

Cyclin D1	EC	AC	LNM	5-year survival rate
				Alive	Dead
Positive	13	20	8	9	11
Negative	14	22	8	15	7
Total	27	42	16	24	18

Table 2 Relationship between cyclin D1 expression with age, lymph node metastasis (LDM) and histological grades (HG) in patients with advanced gastric carcinoma

Cyclin D1	Age (yr)		LDM		HD
	> 60	< 60	Positive	Negative	I	II	III
Positive	14	6	8	12	5	11	5
Negative	16	6	8	14	4	12	4